You searched for "diagnostic"
BPS – a diagnostic enigma
1 July 2015
| Arun K Sharma
|
URO - Functional / Reconstructive Urology
This article from a London teaching hospital presents the results of a Medline search about challenges in bladder pain syndrome. All the known definitions from the American Urological Association (AUA), European Association of Urology (EAU), etc. are given while the...
Medical statistics for urologists: part 3 – diagnostic testing
1 July 2022
| Anika Madaan, Rohan Vyas, Sanjeev Madaan
Following on from the first two parts of this series (see Part 1 here, and Part 2 here), this final article aims to demonstrate how the theory of statistics applies to medical diagnostics. Probability in diagnostic testing Diagnostic tests refer...
Is TRUS and biopsy obsolete as a diagnostic test for prostate cancer: refining the perineal biopsy technique?
1 March 2015
| Mark Harris
|
URO - Urologic Oncology
Whilst there has been a dramatic shift in how patients are investigated for potential prostate cancer, transrectal ultrasound (TRUS) and biopsy remains the most commonly used technique for tissue sampling. In this single centre, retrospective analysis, 634 men, over a...
New techniques in UTI diagnosis
12 September 2023
| Angela Kabia, Jelizaveta Pereca, Alison Downey
|
URO - Functional / Reconstructive Urology, URO - Infection
Urinary tract infection (UTI) is a common reason for seeking medical care in both primary and secondary settings. Half of women will have at least one episode of cystitis in their lifetime, and a third of them will have experienced...
Developing and validating a new nomogram for diagnosing BOO in women
5 November 2019
| Jay Khastgir
|
URO - Neurourology
Bladder outlet obstruction (BOO) in women is thought to be present in between 2.7% and 27%. Causes of BOO in women may be anatomical or functional. Yet, unlike the diagnosis in men, there is no standard definition for BOO in...
Why bother? Metabolic screening for stone formers
1 May 2016
| Ciaran Lynch
|
URO - Endourology & Stones
Introduction Despite the considerable increase in the incidence of stone disease in the UK and elsewhere in recent years, urologists have engaged with preventative strategies to only a limited degree. With mounting evidence of the strong correlation between obesity and...
Prostate cancer series: diagnostics 2
4 March 2025
| Abida Sultana, Hossam Mahrous, Anna Moore, Chara Ntala
|
URO - Urologic Oncology, URO - Core Urology, URO - Uroradiology
- Click here for Part 1 - A 68-year-old male was referred to the two-week wait prostatic clinic with a serum prostate specific antigen (PSA) of 17. He had no bothersome lower urinary tract symptoms, relevant past medical history or...
Rishi Sunak joins Prostate Cancer Research as an ambassador
26 February 2025
|
Charities, Research & Development
Rishi Sunak with three prostate cancer patients at the Oxford BioDynamics labs. (From left to right: Dafydd Charles, Briane Milne, Rishi Sunak, Alfred Samuels). Former UK Prime Minister Rishi Sunak has joined Prostate Cancer Research as an ambassador, to champion...
Fertility Focus Issue I
A deep-dive into the management of male fertility issues in the field of urology, expertly sub-edited by Jonathan Ramsay. Supplement Co-ordinating Editor Jonathan Ramsay: “These authoritative reviews explore what urologists are able to do for sub-fertile men – it is...BUI (Bristol Urological Institute) Advanced Urodynamics Course
9 September 2024
The course looks at the role of urodynamics (UDS) in more complex patients including those who present diagnostic and management challenges. Intended delegates: doctors, nurses, technicians and/or allied health-care professionals (AHPs) with extensive urodynamic experience. Delegates will be asked to submit their own “problem cases” for discussion.
Prostate Cancer Diagnosis – PSA, Biopsy and Beyond
The danger of many of the texts which deal with this rapidly changing field is that by the time the texts are published they are out of date. This book however remains fresh, in part because it acknowledges that there...APCCC (Advanced Prostate Cancer Consensus Conference) Diagnostics 2025
27 February 2025
-28 February 2025
The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid and tissue based biomarkers as well as the recent introduction of PSMA PET imaging have significantly advanced the field, challenging some of the old grounds of truth.
